Get started
Work

FIGURE 1 from A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

Year: 2023
Type: other
Abstract: Treatment response duration and follow-up of patients enrolled in the phase I trial. Swimmer lane plot of time on study, noting the period from prior neoadjuvant chemotherapy to study start in the 4 patients who had prior treatment, the period of time on study drugs, the pathologic response assessment, timing of surgery, and follow-up period with events of progression or death.
DOI: 10.1158/2767-9764.24018730.v1
Authors: Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4386091409
Cites:
Cited by:
Related to: 10